JPS60202822A - 抗ウイルス薬 - Google Patents

抗ウイルス薬

Info

Publication number
JPS60202822A
JPS60202822A JP59059844A JP5984484A JPS60202822A JP S60202822 A JPS60202822 A JP S60202822A JP 59059844 A JP59059844 A JP 59059844A JP 5984484 A JP5984484 A JP 5984484A JP S60202822 A JPS60202822 A JP S60202822A
Authority
JP
Japan
Prior art keywords
methyl
antiviral agent
compound
infectious diseases
daily dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59059844A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0347251B2 (enExample
Inventor
Chiaki Nishimura
西村　千昭
Satoru Ikeda
池田　了
Takeshi Akimoto
健 秋元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP59059844A priority Critical patent/JPS60202822A/ja
Publication of JPS60202822A publication Critical patent/JPS60202822A/ja
Publication of JPH0347251B2 publication Critical patent/JPH0347251B2/ja
Granted legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59059844A 1984-03-28 1984-03-28 抗ウイルス薬 Granted JPS60202822A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59059844A JPS60202822A (ja) 1984-03-28 1984-03-28 抗ウイルス薬

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59059844A JPS60202822A (ja) 1984-03-28 1984-03-28 抗ウイルス薬

Publications (2)

Publication Number Publication Date
JPS60202822A true JPS60202822A (ja) 1985-10-14
JPH0347251B2 JPH0347251B2 (enExample) 1991-07-18

Family

ID=13124923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59059844A Granted JPS60202822A (ja) 1984-03-28 1984-03-28 抗ウイルス薬

Country Status (1)

Country Link
JP (1) JPS60202822A (enExample)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990013542A1 (en) * 1989-04-28 1990-11-15 Daiichi Pharmaceutical Co., Ltd. Anti-hiv drug
US5175160A (en) * 1988-08-09 1992-12-29 Daiichi Pharmaceutical Co., Ltd. Antimicrobial agent for animals
AU638421B2 (en) * 1989-04-28 1993-07-01 Daiichi Pharmaceutical Co., Ltd. An anti-human immunodeficiency virus composition
JPH0682976U (ja) * 1993-05-19 1994-11-29 西川産業株式会社 二重蒲団
WO1998042341A1 (en) * 1997-03-25 1998-10-01 Sankyo Company, Limited Anti-fiv agent
WO1999033835A1 (en) * 1997-12-24 1999-07-08 Sankyo Company, Limited Fused-ring quinolinecarboxylic acid derivatives
US9326936B2 (en) 2008-10-07 2016-05-03 Raptor Pharmaceuticals, Inc. Aerosol fluoroquinolone formulations for improved pharmacokinetics
RU2583890C2 (ru) * 2014-08-19 2016-05-10 Федеральное государственное бюджетное образовательное учреждение высшего образования "Белгородский государственный аграрный университет имени В.Я. Горина" Способ лечения гингивитов, пародонтитов и зубного камня у собак
US9700564B2 (en) 2009-09-04 2017-07-11 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US10987357B2 (en) 2005-05-18 2021-04-27 Horizon Orphan, LLC Aerosolized fluoroquinolones and uses thereof
US11020481B2 (en) 2008-10-07 2021-06-01 Horizon Orphan Llc Topical use of levofloxacin for reducing lung inflammation

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175160A (en) * 1988-08-09 1992-12-29 Daiichi Pharmaceutical Co., Ltd. Antimicrobial agent for animals
WO1990013542A1 (en) * 1989-04-28 1990-11-15 Daiichi Pharmaceutical Co., Ltd. Anti-hiv drug
AU638421B2 (en) * 1989-04-28 1993-07-01 Daiichi Pharmaceutical Co., Ltd. An anti-human immunodeficiency virus composition
JPH0682976U (ja) * 1993-05-19 1994-11-29 西川産業株式会社 二重蒲団
WO1998042341A1 (en) * 1997-03-25 1998-10-01 Sankyo Company, Limited Anti-fiv agent
WO1999033835A1 (en) * 1997-12-24 1999-07-08 Sankyo Company, Limited Fused-ring quinolinecarboxylic acid derivatives
US10987357B2 (en) 2005-05-18 2021-04-27 Horizon Orphan, LLC Aerosolized fluoroquinolones and uses thereof
US10722519B2 (en) 2008-10-07 2020-07-28 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
US9717738B2 (en) 2008-10-07 2017-08-01 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
US10149854B2 (en) 2008-10-07 2018-12-11 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
US9326936B2 (en) 2008-10-07 2016-05-03 Raptor Pharmaceuticals, Inc. Aerosol fluoroquinolone formulations for improved pharmacokinetics
US11020481B2 (en) 2008-10-07 2021-06-01 Horizon Orphan Llc Topical use of levofloxacin for reducing lung inflammation
US9700564B2 (en) 2009-09-04 2017-07-11 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US10231975B2 (en) 2009-09-04 2019-03-19 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US10792289B2 (en) 2009-09-04 2020-10-06 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
RU2583890C2 (ru) * 2014-08-19 2016-05-10 Федеральное государственное бюджетное образовательное учреждение высшего образования "Белгородский государственный аграрный университет имени В.Я. Горина" Способ лечения гингивитов, пародонтитов и зубного камня у собак

Also Published As

Publication number Publication date
JPH0347251B2 (enExample) 1991-07-18

Similar Documents

Publication Publication Date Title
US4879277A (en) Antiviral compositions and methods
JPS60202822A (ja) 抗ウイルス薬
JPS59130223A (ja) 相乗作用を示す抗ヘルペス組成物
Taylor et al. Protection against Japanese encephalitis virus in mice and hamsters by treatment with carboxymethylacridanone, a potent interferon inducer
CA2109435C (en) Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals
WO1991002529A2 (en) Product and method for killing abnormal vertebrate cells
JP2724711B2 (ja) 医薬品生成物
ES2105923A1 (es) Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv).
IL106491A0 (en) Anti viral preparations
US5840763A (en) Treatment of a latent infection of herpes viruses
Steffenhagen et al. Evaluation of 6-azauridine and S-iododeoxyuridine in the treatment of experimental viral infections
CA1336491C (en) Antiviral pharmaceutical composition
US20230398090A1 (en) Method of treating coronavirus infection by administration of ethyl mercury or thiol derivative thereof
JPH0768136B2 (ja) 抗ウイルス治療
US4230725A (en) Antiviral agent
KR0141648B1 (ko) B형 바이러스(hbv)성 감염의 예방 및 치료용 약학적 제제
RU1822787C (ru) Противогриппозное средство
AU690159B2 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
RU2333752C1 (ru) Противовирусное средство
KR100382707B1 (ko) 잠재적허피스바이러스감염의치료및예방을위한아미노퓨린항바이러스제의용도
JPH11501625A (ja) ヒト・ヘルペスウイルス−８の治療に対するペンシクロビルの使用
JPH07188032A (ja) インフルエンザ治療薬
Schwartz et al. Antiviral agents
EP1594507A2 (en) Novel antiherpes drug combinations
CZ2020210A3 (cs) Léková forma s obsahem chininu a jeho solí pro perorální aplikaci